DE69636597D1 - Endothelin rezeptor antagonisten - Google Patents

Endothelin rezeptor antagonisten

Info

Publication number
DE69636597D1
DE69636597D1 DE69636597T DE69636597T DE69636597D1 DE 69636597 D1 DE69636597 D1 DE 69636597D1 DE 69636597 T DE69636597 T DE 69636597T DE 69636597 T DE69636597 T DE 69636597T DE 69636597 D1 DE69636597 D1 DE 69636597D1
Authority
DE
Germany
Prior art keywords
receptor antagonists
endothelin receptor
endothelin
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636597T
Other languages
English (en)
Other versions
DE69636597T2 (de
Inventor
Ignacio Luengo
Duncan Elliott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of DE69636597D1 publication Critical patent/DE69636597D1/de
Application granted granted Critical
Publication of DE69636597T2 publication Critical patent/DE69636597T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE69636597T 1995-08-02 1996-08-02 Endothelin rezeptor antagonisten Expired - Fee Related DE69636597T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US179295P 1995-08-02 1995-08-02
US1792 1995-08-02
US1098296P 1996-02-01 1996-02-01
US10982 1996-02-01
PCT/US1996/012581 WO1997004772A1 (en) 1995-08-02 1996-08-02 Endothelin receptor antagonists

Publications (2)

Publication Number Publication Date
DE69636597D1 true DE69636597D1 (de) 2006-11-16
DE69636597T2 DE69636597T2 (de) 2007-08-16

Family

ID=26669471

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69636597T Expired - Fee Related DE69636597T2 (de) 1995-08-02 1996-08-02 Endothelin rezeptor antagonisten
DE69619116T Expired - Fee Related DE69619116T2 (de) 1995-08-02 1996-08-02 Endothelinrezeptorantagonisten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69619116T Expired - Fee Related DE69619116T2 (de) 1995-08-02 1996-08-02 Endothelinrezeptorantagonisten

Country Status (25)

Country Link
US (5) US5969151A (de)
EP (2) EP0841925B1 (de)
JP (2) JP2001517195A (de)
KR (1) KR19990036032A (de)
CN (1) CN1196680A (de)
AP (1) AP9801182A0 (de)
AT (1) ATE341324T1 (de)
AU (2) AU717172B2 (de)
BG (1) BG102229A (de)
BR (1) BR9609914A (de)
CA (2) CA2228296A1 (de)
CZ (1) CZ30498A3 (de)
DE (2) DE69636597T2 (de)
EA (1) EA000952B1 (de)
ES (2) ES2273350T3 (de)
HU (1) HU220776B1 (de)
MX (1) MX9800975A (de)
NO (1) NO980422L (de)
NZ (1) NZ315846A (de)
OA (1) OA10755A (de)
PL (1) PL184272B1 (de)
RO (1) RO115802B1 (de)
SK (1) SK282584B6 (de)
TR (1) TR199800152T1 (de)
WO (2) WO1997004772A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017426A1 (es) 1997-12-08 2001-09-05 Smithkline Beecham Corp Sal de monoargininilo del acido (e)-3-[1-n-butil-5-[2-(2-carboxifenil)metoxi-4-clorofenil]-1h-pirazol-4-il]-2-[(5-metoxi-2,3-dihidrobenzofuran-6-il)metil]-prop-2-enoico, composicion farmaceutica que la contiene, su uso para la manufactura de un medicamento y procedimiento para su preparacion
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
AU2003247622A1 (en) * 2002-06-27 2004-01-19 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
WO2006075955A1 (en) * 2005-01-13 2006-07-20 Astrazeneca Ab Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease
US7521435B2 (en) * 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
US8012038B1 (en) 2008-12-11 2011-09-06 Taylor Made Golf Company, Inc. Golf club head
US10086240B1 (en) 2015-08-14 2018-10-02 Taylor Made Golf Company, Inc. Golf club head
US10626096B2 (en) 2015-11-24 2020-04-21 Sanford Burnham Prebys Medical Discovery Institute Azole derivatives as apelin receptor agonist
US10773135B1 (en) 2019-08-28 2020-09-15 Taylor Made Golf Company, Inc. Golf club head

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1937241A1 (de) * 1968-08-02 1970-02-19 Sumitomo Chemical Co 3,5-Dioxopyrazolidinderivate und Verfahren zu ihrer Herstellung
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
WO1992010189A1 (en) * 1990-12-14 1992-06-25 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
FR2682379B1 (fr) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en) * 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
CN1049219C (zh) * 1993-08-18 2000-02-09 万有制药株式会社 具有内皮素拮抗活性的芳香杂环并环戊烯衍生物
IL111613A0 (en) * 1993-11-12 1995-01-24 Rhone Poulenc Rorer Ltd Substituted phenyl compounds, their preparation and pharmaceutical compositions containing them
ATE217619T1 (de) * 1994-09-02 2002-06-15 Smithkline Beecham Corp Endothelin-rezeptor-antagonisten

Also Published As

Publication number Publication date
AU6764596A (en) 1997-02-26
CZ30498A3 (cs) 1998-07-15
EA000952B1 (ru) 2000-08-28
JPH11511133A (ja) 1999-09-28
BR9609914A (pt) 1999-07-06
HUP9902817A2 (hu) 1999-12-28
NO980422L (no) 1998-03-24
HU220776B1 (hu) 2002-05-28
RO115802B1 (ro) 2000-06-30
WO1997004772A1 (en) 1997-02-13
CA2228296A1 (en) 1997-02-13
EP0843551B1 (de) 2002-02-06
US6353116B1 (en) 2002-03-05
EP0841925A4 (de) 2001-10-17
CA2228293A1 (en) 1997-02-13
AU6646396A (en) 1997-02-26
PL184272B1 (pl) 2002-09-30
PL324745A1 (en) 1998-06-08
HUP9902817A3 (en) 2001-03-28
KR19990036032A (ko) 1999-05-25
ATE341324T1 (de) 2006-10-15
EP0843551A1 (de) 1998-05-27
SK282584B6 (sk) 2002-10-08
AU717172B2 (en) 2000-03-16
US5969151A (en) 1999-10-19
CN1196680A (zh) 1998-10-21
OA10755A (en) 2002-12-13
JP2001517195A (ja) 2001-10-02
ES2171697T3 (es) 2002-09-16
TR199800152T1 (xx) 1998-05-21
WO1997004773A1 (en) 1997-02-13
ES2273350T3 (es) 2007-05-01
EP0841925A1 (de) 1998-05-20
DE69619116D1 (de) 2002-03-21
BG102229A (en) 1998-09-30
EP0843551A4 (de) 1998-08-12
US20020072614A1 (en) 2002-06-13
SK11398A3 (en) 1998-07-08
US6482956B2 (en) 2002-11-19
AP9801182A0 (en) 1998-01-31
EP0841925B1 (de) 2006-10-04
US6096897A (en) 2000-08-01
NO980422D0 (no) 1998-01-30
US5958968A (en) 1999-09-28
EA199800185A1 (ru) 1998-10-29
NZ315846A (en) 1999-01-28
DE69619116T2 (de) 2002-09-19
MX9800975A (es) 1998-04-30
DE69636597T2 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
FI960953A0 (fi) Endoteliinireseptoriantagonisteja
NO972016D0 (no) Indolyl-Y-reseptorantagonister
BR9407933A (pt) Antagonistas de receptores de endotelina
BR9612381A (pt) Antagonistas receptores vitronectina
NO983003D0 (no) Vitronectin-reseptor-antagonister
NO983002D0 (no) Vitronectin-reseptor-antagonister
DE69327720T2 (de) Endothelin rezeptor antagonisten
DE69734833D1 (de) Vitronektin rezeptor antagonisten
FI960516A0 (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
BR9406572A (pt) Antagonistas receptores do endotelin
DE59610900D1 (de) Adhäsionsrezeptor-Antagonisten
ID24726A (id) Antagonis-antagonis reseptor trombin
ID24162A (id) Antagonis-antagonis reseptor vitronektin
BR9507220A (pt) Antagonistas de receptores de endotelina
DE69636597D1 (de) Endothelin rezeptor antagonisten
NO972612D0 (no) Pyridazoner som endotelinreseptorantagonister
DE69616364D1 (de) Endothelinrezeptorantagonisten
HU9602054D0 (en) Endothelin receptor antagonists
BR9603432A (pt) Antagonistas de receptores de endotelina
EP0841926A4 (de) Endothelinrezeptorantagonist
EP0841916A4 (de) Endothelinrezeptorantagonisten
EP0868180A4 (de) Endothelinm rezeptor antogonisten
ZA966592B (en) Endothelin receptor antagonists
GB9510203D0 (en) Novel endothelin receptor antagonists

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee